Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study

PURPOSE: This study aims to investigate the effect of sorafenib plus Transarterial Chemoembolization (TACE) treatment on inhibiting portal vein invasion in patients with intermediate stage HCC. MATERIALS AND METHODS: The consecutive medical records of patients with HCC were retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Qi, Zhang, Hongsen, Xiong, Bin, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668016/
https://www.ncbi.nlm.nih.gov/pubmed/29108283
http://dx.doi.org/10.18632/oncotarget.20745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668016/
https://www.ncbi.nlm.nih.gov/pubmed/29108283
http://dx.doi.org/10.18632/oncotarget.20745

Ejemplares similares